
Research team
Dr. Mohammed Almutairi
MSc, PhD · Assistant Professor of Pharmacology and Toxicology
College of Pharmacy, King Saud University, Riyadh 11451
Office 1B37, Building 23
malmotyre@ksu.edu.sa
Google Scholar · ORCID
Background
Professional Summary
Dr. Almutairi is an Assistant Professor of Pharmacology and Toxicology at the College of Pharmacy, King Saud University. He earned his PhD in Pharmacology and Toxicology from the University of Kansas, USA.
His research focuses on understanding and targeting the molecular mechanisms involved in the pathogenesis of diabetes and neurodegenerative disorders. He also studies age-dependent abnormalities in mitochondria and develops targeted strategies to improve mitochondrial quality and activity in aging models.
His work employs a variety of techniques, including cell culture, animal surgery, cytotoxicity, oxidative stress and mitochondrial function assays, western blotting, real-time PCR, and flow cytometry.
Dr. Almutairi actively trains and supervises graduate and undergraduate students, guiding them in developing their research projects and fostering a collaborative environment that encourages exploration and creativity in molecular pharmacology and toxicology.
Research Interests
- Interactions between neuropharmacological agents and neurotoxic insults at the cellular and molecular levels
- Neurotoxic effects of emerging toxicants, such as nanoparticles and synthetic drugs
- Mitochondria-targeted neuroprotective agents and their pharmacological potential in age-associated CNS diseases
Research Goals
- Identifying and developing promising therapeutic approaches to rescue cells from abnormal conditions such as hyperglycemia, inflammation, oxidative stress and trace metal toxicity
- Screening for novel compounds to protect neurons from the neurotoxic effects of hyperglycemia, inflammation, oxidative stress, and mitochondrial dysfunction
- Understanding the mitochondrial theory of aging and implementing interventional approaches to delay mitochondrial aging and extend longevity
Active now
Current Projects
Investigating the neuroprotective effects of novel compounds against aging-related cellular damage.
Assessing the cytotoxicity of heavy metals, such as arsenic and iron, in their various states in in vitro models.
Training and supervision
Graduate and PharmD Students
Current
- Faisal Nasser (PharmD)
- Abdullah Alsheikh (PharmD)
Graduated
- Fahad Almutairi, MSc
- Mohammed Alatabani, PharmD
- Abdulaziz Alsaikhan, PharmD
Selected Publications
For a complete list, see Google Scholar or ORCID.
- Alanazi MM, Albaker AB, Alzaagi LA, Alsabhan JF, Alasmari F, Almutairi MM, Alharbi MS, Alasmari AF, Alqahtani F, Alsanea S. Oxytocin Protects PC12 Cells Against β-Amyloid-Induced Cell Injury. Pharmaceuticals. 2025. doi:10.3390/ph18030390
- Almutairi MM, Althekair A, Almutairi F, Alatabani M, Alsaikhan A. Mitochondrial dysfunction and mitophagy in ADHD: Cellular and molecular mechanisms. Saudi Pharm J. 2024.
- Alanazi W, Alharbi T, Bin Anzan K, Alyahiya M, Elnagar D, Alanazi M, Almutairi MM, Alhamami H, Albogami A, Mohany M. The Role of Dapagliflozin in the Modulation of Hypothermia and Renal Injury Caused by Septic Shock in Euglycemic and Hyperglycemic Rat Models. Curr Pharmacol. 2024;17:e18761429329635.
- Alhudaithi S, Kalam M, Binobaid L, Ali R, Almutairi MM, Qamar W, Hithlayn H, Almutairi A, Alshememry A. Sorafenib and Piperine co-loaded PLGA nanoparticles: Development, characterization, and anti-cancer activity against hepatocellular carcinoma cell line. Saudi Pharm J. 2024.
- Alsaleh N, Aljarbou A, Assal M, Assiri M, Almutairi MM, As Sobeai H, Alshamrani A, Almudimeegh S, Hatshan M, Adil S. Synthesis, Characterization, and Toxicity Assessment of Zinc Oxide-Doped Manganese Oxide Nanoparticles in a Macrophage Model. Pharmaceuticals. 2024;17(2):168.
- Alqahtani F, Ali Y, Almutairi MM, Alotaibi A, Imran I, Alshammari M, Alshememry A, Alsharari S, Albekairi T. Therapeutic benefits of quercetin in traumatic brain injury model exposed to cigarette smoke. Saudi Pharm J. 2024.
- Assiri M, Albekairi T, Ansari M, Nadeem A, Attia S, Albakheet S, Shahid M, Aldossari A, Almutairi MM, Almanaa T, Alwetaid M, Ahmad S. The Exposure to Lead (Pb) Exacerbates Immunological Abnormalities in BTBR T+ Itpr3tf/J Mice through the Regulation of Signaling Pathways Relevant to T Cells. Int J Mol Sci. 2023.
- Alsaleh N, Assiri M, Aljarbou A, Almutairi MM, As Sobeai H, Alshamrani A, Almudimeegh S. Adverse Responses following Exposure to Subtoxic Concentrations of Zinc Oxide and Nickle Oxide Nanoparticles in the Raw 264.7 Cells. Toxics. 2023.
- Alanazi M, Ansari M, Nadeem A, Attia S, Bakheet S, Almazroua H, Aldossari A, Almutairi MM, Albekairi T, Hussein M, Alhamamah M, Ahmad S. Cadmium Exposure Is Associated with Behavioral Deficits and Neuroimmune Dysfunction in BTBR T+ Itpr3tf/J Mice. Int J Mol Sci. 2023.
- Alghaith A, Mahrous G, Shazly G, Zidan D, Alhamed A, Alginyah M, Almutairi MM, Syed S. The Optimization and Evaluation of Flibanserin Fast-Dissolving Oral Films. Polymers. 2022.
- Alotaibi A, Alsaleh N, Aljasham A, Tawfik E, Almutairi MM, Assiri M, Alkholief M, Almutairi M. Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates. Antibiotics. 2022.
- Al-Harbi N, Sheikh A, Almutairi MM, Alanazi A, Ibrahim K, Alqarni S, Alqahtani F, Alhazzani K, Alharbi M, Alasmari F, Nadeem A. Lck signaling inhibition causes improvement in clinical features of psoriatic inflammation through reduction in inflammatory cytokines in CD4+ T cells in imiquimod mouse model. Cell Immunol. 2022.
- Almutairi MM, Sivandzade F, Albekairi T, Alqahtani F, Cucullo L. Neuro-inflammation and its impact on the pathogenesis of COVID-19. Front Med. 2021.